Private limited company (pre-2019) · founded 2018 · 8 years activeFinisterraestraat 24, 1000 Brussel, BelgiumKBO/BCE: BE 0704.609.285
Summary
PHARMA RUE NEUVE has been active since 2018 and the Belgian State Gazette contains no insolvency signals. The CBE does carry 1 administrative register entry (see administrative flags). The 2025 annual accounts show equity of €12,400. Equity remains stable across the filed fiscal years (±0% per year). The computed 12-month bankruptcy probability is 1.3% (low).
Signals- Latest accounts 31 days late; 1 of the last 3 late- No main activity registered- No establishment unit in the KBO- Administrative warnings in the KBO publications+ Liquidity: cash €12,400Filed after the deadlineShow the evidence
Checked score
No current score
Checked score
A figure from 0 to 100: the higher it is, the smaller the chance that the company goes bankrupt within twelve months. The band, from Critical to Excellent, follows from that chance; within the band, how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
Insufficient figures
A score requires measurable solvency, liquidity and profitability. Missing figures are not a judgement about the company.
Bankruptcy probability, 12 months
Bankruptcy probability
The chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. 0.2% means about 2 in 1,000 comparable companies. The higher it is, the shorter the payment term to agree.
1.3%Low
0%0.5%1.5%4%10%≥ 25%
About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months11-2024: 1.2%12-2024: 1.1%▼ -0.1 percentage points vs 11-202401-2025: 1.1%● unchanged vs 12-2024lowest value02-2025: 1.1%● unchanged vs 01-202503-2025: 1.1%● unchanged vs 02-202504-2025: 1.2%▲ +0.1 percentage points vs 03-202505-2025: 1.2%● unchanged vs 04-202506-2025: 1.2%● unchanged vs 05-202507-2025: 1.4%▲ +0.2 percentage points vs 06-202508-2025: 2.3%▲ +0.9 percentage points vs 07-2025highest value09-2025: 1.1%▼ -1.2 percentage points vs 08-202510-2025: 1.1%● unchanged vs 09-202511-2025: 1.1%● unchanged vs 10-202512-2025: 1.1%● unchanged vs 11-202501-2026: 1.1%● unchanged vs 12-202502-2026: 1.2%▲ +0.1 percentage points vs 01-202603-2026: 1.2%● unchanged vs 02-202604-2026: 1.3%▲ +0.1 percentage points vs 03-202605-2026: 1.2%▼ -0.1 percentage points vs 04-202606-2026: 1.2%● unchanged vs 05-202607-2026: 1.2%● unchanged vs 06-202608-2026: 2.2%▲ +1.0 percentage point vs 07-202609-2026: 1.6%▼ -0.6 percentage points vs 08-202610-2026: 1.3%▼ -0.3 percentage points vs 09-2026
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
This company filed its last 4 accounts on average 28 days after the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.
+
raises risk · Administrative warnings in the KBO publications
1 publication by the FPS Economy about this company, such as a strike-off for address, accounts or UBO, or its withdrawal.
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 28 August (4 of the last 4 filed years within 30 days of that day).